Farther Finance Advisors LLC Has $97,000 Stake in Align Technology, Inc. (NASDAQ:ALGN)

Farther Finance Advisors LLC lowered its position in shares of Align Technology, Inc. (NASDAQ:ALGN) by 22.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 464 shares of the medical equipment provider’s stock after selling 132 shares during the period. Farther Finance Advisors LLC’s holdings in Align Technology were worth $97,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently made changes to their positions in ALGN. True Wealth Design LLC increased its stake in shares of Align Technology by 10,700.0% during the third quarter. True Wealth Design LLC now owns 108 shares of the medical equipment provider’s stock worth $27,000 after purchasing an additional 107 shares during the period. Neo Ivy Capital Management bought a new position in shares of Align Technology during the third quarter worth approximately $32,000. Private Trust Co. NA increased its stake in shares of Align Technology by 113.4% during the fourth quarter. Private Trust Co. NA now owns 175 shares of the medical equipment provider’s stock worth $36,000 after purchasing an additional 93 shares during the period. Versant Capital Management Inc increased its stake in shares of Align Technology by 212.2% during the fourth quarter. Versant Capital Management Inc now owns 231 shares of the medical equipment provider’s stock worth $48,000 after purchasing an additional 157 shares during the period. Finally, Newbridge Financial Services Group Inc. bought a new position in shares of Align Technology during the fourth quarter worth approximately $52,000. Institutional investors own 88.43% of the company’s stock.

Align Technology Stock Down 0.1 %

NASDAQ ALGN opened at $168.61 on Friday. Align Technology, Inc. has a twelve month low of $158.13 and a twelve month high of $331.64. The company has a market cap of $12.41 billion, a price-to-earnings ratio of 30.06, a price-to-earnings-growth ratio of 2.24 and a beta of 1.69. The business’s fifty day moving average is $198.78 and its 200 day moving average is $216.64.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $1.96 earnings per share for the quarter, missing the consensus estimate of $2.43 by ($0.47). Align Technology had a net margin of 10.54% and a return on equity of 13.84%. On average, research analysts anticipate that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ALGN has been the topic of a number of recent research reports. Leerink Partners upgraded Align Technology from a “market perform” rating to an “outperform” rating and raised their price objective for the stock from $235.00 to $280.00 in a research note on Monday, January 6th. Wells Fargo & Company initiated coverage on Align Technology in a research note on Friday, February 14th. They set an “overweight” rating and a $255.00 price objective on the stock. Jefferies Financial Group lowered their price objective on Align Technology from $285.00 to $260.00 and set a “buy” rating on the stock in a research note on Thursday, January 23rd. Bank of America raised their price objective on Align Technology from $200.00 to $206.00 and gave the stock an “underperform” rating in a research note on Friday, December 13th. Finally, Evercore ISI raised their price objective on Align Technology from $240.00 to $260.00 and gave the stock an “outperform” rating in a research note on Thursday, February 6th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $266.73.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.